Search
for
Sort by
Research 271–300 of 1000+
- Acanthosis nigricans and the metabolic syndrome
- Association of Insulin Resistance with Hyperandrogenia in Women
- Long COVID syndrome: An unfolding enigma
- Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Cultural Sensitivity and Challenges in Management of the Transgender Patient With ESRD in Transplantation
- Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?
- Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?
- The Postnatal Offspring of Finasteride-Treated Male Rats Shows Hyperglycaemia, Elevated Hepatic Glycogen Storage and Altered GLUT2, IR, and AR Expression in the Liver
- Endocannabinoid activation and polycystic ovary syndrome: A systematic review
- Long-Term Morbidity of PCOS
- Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]
- Correlation of trichoscopic findings with clinico-epidemiological factors in male pattern&nbsp;<span style="font-size: 1rem;">hairloss: A cross-sectional study from a tertiary care center in Chengalpattu</span>
- Pathophysiology and Complications of Polycystic Ovary Syndrome (PCOS): A Stepwise Visual Infographic
- Pathophysiology and Complications of Polycystic Ovary Syndrome (PCOS): A Stepwise Visual Infographic
- Síndrome dos Ovários Policísticos: Uma revisão de literatura
- SAT-510 Association of Myotonic Dystrophy with Autoimmune Endocrinopathies and Thyroid Carcinoma
- CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE
- Update on Polycystic Ovary Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- 463 Comorbid conditions associated with alopecia areata: A systematic review and update
- Post-Finasteride Syndrome – When will we Get the Courage to Fight the Dictating Pharma Industry – Despite Awareness of “Sexual, Neurological and Metabolic Side Effects in Young Men for Over a Decade”
- Clinical aspects of the metabolic syndrome
- Polycystic ovary syndrome and impact on health
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Recognizing polycystic ovary syndrome in the primary care setting
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Polycystic Ovary Syndrome (PCOS): Causes, Symptoms, Diagnosis & Treatments